Retrospective Study Diving and hyperbaric medicine 2020

Decompression illness treated at the Geneva hyperbaric facility 2010-2016: A retrospective analysis of local cases.

Thaler J, Pignel R, Magnan MA, Pellegrini M, Louge P — Diving and hyperbaric medicine, 2020

View Original on PubMed PMID 33325018

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers retrospectively analyzed data from 92 patients treated for decompression illness with hyperbaric oxygen at the Geneva hyperbaric facility between 2010 and 2016.

What They Found

Out of 92 patients, 64 presented with neurological and 28 with mild decompression illness (DCI). Neurological DCI cases primarily involved spinal (55%) and vestibular (36%) symptoms, with 25% experiencing persisting deficits after treatment. The median time to treatment was 6 hours, and no adverse effects of hyperbaric oxygen were observed.

Canadian Relevance

This study has no direct Canadian connection.

Study Limitations

As a retrospective study, it is limited by potential biases and the completeness of available data.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type	Retrospective Study
Category	Neurological
Source	Pubmed
PubMed ID	33325018
Year Published	2020
Journal	Diving and hyperbaric medicine
MeSH Terms	Aged; Decompression; Decompression Sickness; Diving; Embolism, Air; Humans; Hyperbaric Oxygenation; Retrospective Studies

Related Research

PLoS ONE | 2013 RCT

Hyperbaric oxygen induces late neuroplasticity in post stroke patients--randomized, prospective trial.

Efrati S, Fishlev G, Bechor Y, et al.

J Neurotrauma | 2018 Systematic Review

Hyperbaric oxygen therapy in the treatment of acute severe traumatic brain injury: a systematic review

Daly S, Thorpe M, Rockswold S, et al.

J Neurotrauma | 2012 Pilot Study

A phase I study of low-pressure hyperbaric oxygen therapy for blast-induced post-concussion syndrome and PTSD

Harch PG, Andrews SR, Fogarty EF, et al.

Scientific Reports | 2022 RCT

Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.

Hadanny A, Zilberman-Itskovich S, Catalogna M, et al.

PLoS ONE | 2013 RCT

Hyperbaric oxygen therapy can improve post concussion syndrome years after mild traumatic brain injury — randomized prospective trial

Boussi-Gross R, Golan H, Fishlev G, et al.

See all Neurological research

View on PubMed Back to Research Library

Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology